DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIO CAPITAL LLC | 30,573 | $7,585,161 | 4.11% |
| STONE RUN CAPITAL, LLC | 33,397 | $8,285,796 | 4.06% |
| Sustainable Growth Advisers, LP | 3,194,791 | $792,627,647 | 4.03% |
| Baker Chad R | 64,290 | $15,950,349 | 4.03% |
| COMPASS CAPITAL MANAGEMENT, INC | 205,971 | $51,101,435 | 4.02% |
| Allen Investment Management, LLC | 1,100,399 | $273,009,091 | 3.99% |
| Hikari Power Ltd | 185,170 | $40,721 | 3.98% |
| Progressive Investment Management Corp | 48,928 | $12,139,037 | 3.94% |
| Capital Investment Services of America, Inc. | 135,741 | $33,677,342 | 3.91% |
| Broderick Brian C | 56,741 | $14,077,441 | 3.88% |
| Page Arthur B | 14,977 | $3,715,793 | 3.85% |
| Akre Capital Management | 1,775,400 | $440,476,740 | 3.82% |
| Reynders McVeigh Capital Management, LLC | 218,670 | $54,252 | 3.73% |
| Ramsay, Stattman, Vela & Price, Inc. | 69,345 | $17,204,495 | 3.73% |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 1,713,531 | $330,677,048 | 3.70% |
| Buffington Mohr McNeal | 65,532 | $16,258,590 | 3.70% |
| Governors Lane LP | 92,300 | $22,899,630 | 3.65% |
| Hemenway Trust Co LLC | 139,210 | $34,538,011 | 3.62% |
| SOMERVILLE KURT F | 72,382 | $17,957,973 | 3.61% |
| KELLY LAWRENCE W & ASSOCIATES INC/CA | 53,333 | $13,231,917 | 3.55% |
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DANAHER CORPORATION's shareholders in Q3 2023. To view DANAHER CORPORATION's shareholder history, click here.